logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

CAMSENSE (06802) issues 1,738,300 shares due to full exercise of the over-allotment option.

date
20:04 28/10/2026
avatar
GMT Eight
CAMSENSE (06802) announced that on October 28, 2026, due to the full exercise of the over-allotment option, it issued 1,738,300 shares at an issue price of HK$58.85 per share.
CAMSENSE (06802) announced that on October 28, 2026, due to the full exercise of the over-allotment option, it issued 1,738,300 shares at an issue price of HK$58.85 per share.
Related Articles
HK Stock
TIAN LUN GAS (01600): Unusual fluctuations in share price and trading volume; the Group's business operations remain normal.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276): HRS-2189 Tablets Approved to Initiate Clinical Trials
HK Stock
SH IND URBAN (00563) subsidiary intends to sell 100% equity of Shanghai Chengkai Jingxiang Real Estate for RMB742 million
TIAN LUN GAS (01600): Unusual fluctuations in share price and trading volume; the Group's business operations remain normal.
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276): HRS-2189 Tablets Approved to Initiate Clinical Trials
HK Stock
SH IND URBAN (00563) subsidiary intends to sell 100% equity of Shanghai Chengkai Jingxiang Real Estate for RMB742 million
HK Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.